Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir +ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia [PDF]
Vojnosanitetski Pregled, 2019 Background/Aim. The era of direct-acting antiviral (DAA) regimen in the treatment of chronic hepatitis C virus (HCV) started in 2011. The aim of this study was to assess the antiviral efficacy and safety of DAA regimen, ombitasvir (OBV)/paritaprevir (PTV)
Simonović-Babić Jasmina +9 more
doaj +1 more source
Моделювання динаміки ринку криптовалют з використанням інструментів машинного навчання
Sistemnì Doslìdženâ ta Informacìjnì Tehnologìï, 2023 Проаналізовано динаміку кон’юнктури ринку криптовалют (Bitcoin) з використанням інструментарію економетричного оцінювання на основі моделей машинного навчання.
Dmytro Martjanov +2 more
doaj +1 more source
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation. [PDF]
PLoS ONE, 2018 ObjectivesThe aim of this multicenter retrospective study was to investigate safety and efficacy of direct acting antiviral (DAA) treatment in the rare subgroup of patients with HCV/HIV-coinfection and advanced liver cirrhosis on the liver transplant ...
Julia M Grottenthaler +20 more
doaj +1 more source
Efficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis [PDF]
International Journal of Medical Arts, 2020 Background: Hepatitis C virus (HCV) infection is associated with more significant morbidity and mortality among dialysis patients than in healthy populations.
Naglaa El-Gendy +3 more
doaj +1 more source
Kidney International Reports, 2019 Introduction: Patients with hepatitis C virus (HCV) infection and chronic kidney disease (CKD) are a high-priority population for treatment. Methods: We performed a post hoc pooled efficacy and safety analysis that included HCV genotype 1–infected ...
David E. Bernstein +11 more
doaj +1 more source
Patterns of olfactory dysfunctions in patients with Parkinson disease
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2020 Background Olfactory dysfunction (OD) is a well-established nonmotor manifestations (NMM) of Parkinson disease (PD) which needs objective assessment for better understanding of the disease pathogenesis.
Khaled Hussein Rashed +6 more
doaj +1 more source
OBV methods. [For solving linear systems Ax = b] [PDF]
, 1979 The properties of OB relaxation of Varga iterative methods are investigated, with particular emphasis on diagonal relaxation. Generalizations of the results of Beauwens and Quenon (SIAM J. Numer. Anal., 13, 615-643 (1976)) are presented, and their relations with the works of Axelsson and Gustafsson are indicated.
openaire +2 more sources
Hepatology Communications, 2018 In adults, treatment of hepatitis C virus (HCV) infection with ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) with or without dasabuvir (DSV) and ±ribavirin (RBV) results in high rates of sustained virologic response (SVR).
Daniel H. Leung +17 more
doaj +1 more source
Anesthesiology and Pain Medicine, 2018 [Abstract not Available]
Önal, Özkan +4 more
openaire +4 more sources
The Heat Is On: Climate Change–Related Challenges and SMEs' R&D Activities
Business Strategy and the Environment, EarlyView.ABSTRACT Investing in R&D is a key way for small‐ and medium‐sized enterprises (SMEs) to develop capabilities that are required to respond to climate change–related challenges. However, the extent to which such challenges affect SMEs' R&D activities remains a critical gap in the literature.
Gráinne Gibson +3 more
wiley +1 more source